This trial is testing two different treatments for people with a certain type of liver cancer. The first group of people will get a drug called Atezolizumab, and the second group will get a different drug called Bevacizumab. The trial will compare how well each treatment works.
1 Primary · 6 Secondary · Reporting Duration: 2 years
Experimental Treatment
70 Total Participants · 2 Treatment Groups
Primary Treatment: Neoadjuvant · No Placebo Group · Phase 2
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: